These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 16600538)
1. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Dillen K; Vandervoort J; Van den Mooter G; Ludwig A Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538 [TBL] [Abstract][Full Text] [Related]
2. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles. Bozdag S; Dillen K; Vandervoort J; Ludwig A J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924 [TBL] [Abstract][Full Text] [Related]
3. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method. Choi SH; Park TG Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477 [TBL] [Abstract][Full Text] [Related]
4. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity. Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236 [TBL] [Abstract][Full Text] [Related]
6. Adhesion of PLGA or Eudragit/PLGA nanoparticles to Staphylococcus and Pseudomonas. Dillen K; Bridts C; Van der Veken P; Cos P; Vandervoort J; Augustyns K; Stevens W; Ludwig A Int J Pharm; 2008 Feb; 349(1-2):234-40. PubMed ID: 17888598 [TBL] [Abstract][Full Text] [Related]
7. The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. Dillen K; Weyenberg W; Vandervoort J; Ludwig A Eur J Pharm Biopharm; 2004 Nov; 58(3):539-49. PubMed ID: 15451528 [TBL] [Abstract][Full Text] [Related]
8. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release. Saxena V; Sadoqi M; Shao J Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634 [TBL] [Abstract][Full Text] [Related]
9. Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Dillen K; Vandervoort J; Van den Mooter G; Verheyden L; Ludwig A Int J Pharm; 2004 May; 275(1-2):171-87. PubMed ID: 15081148 [TBL] [Abstract][Full Text] [Related]
10. Design and optimization of NSAID loaded nanoparticles. Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573 [TBL] [Abstract][Full Text] [Related]
11. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Mainardes RM; Evangelista RC Int J Pharm; 2005 Feb; 290(1-2):137-44. PubMed ID: 15664139 [TBL] [Abstract][Full Text] [Related]
12. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Budhian A; Siegel SJ; Winey KI Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944 [TBL] [Abstract][Full Text] [Related]
13. Impact of bulk and surface properties of some biocompatible hydrophobic polymers on the stability of methylene chloride-in-water mini-emulsions used to prepare nanoparticles by emulsification-solvent evaporation. Babak VG; Baros F; Boulanouar O; Boury F; Fromm M; Kildeeva NR; Ubrich N; Maincent P Colloids Surf B Biointerfaces; 2007 Oct; 59(2):194-207. PubMed ID: 17600692 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
15. Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis. Pillai RR; Somayaji SN; Rabinovich M; Hudson MC; Gonsalves KE Biomed Mater; 2008 Sep; 3(3):034114. PubMed ID: 18708713 [TBL] [Abstract][Full Text] [Related]
16. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release. Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022 [TBL] [Abstract][Full Text] [Related]
17. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles. He W; Horn SW; Hussain MD Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249 [TBL] [Abstract][Full Text] [Related]
18. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles. Glowka E; Sapin-Minet A; Leroy P; Lulek J; Maincent P J Microencapsul; 2010; 27(1):25-36. PubMed ID: 19229671 [TBL] [Abstract][Full Text] [Related]
20. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate. Yin J; Noda Y; Yotsuyanagi T Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]